idarubicin has been researched along with natriuretic peptide, brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartikainen, J; Jantunen, E; Nousiainen, T; Puustinen, J; Rantala, A; Remes, J; Vanninen, E; Vuolteenaho, O | 1 |
| Horácek, JM; Jebavý, L; Malý, J; Praus, R; Pudil, R; Strasová, A; Tichý, M; Zák, P | 1 |
2 other study(ies) available for idarubicin and natriuretic peptide, brain
| Article | Year |
|---|---|
Acute neurohumoral and cardiovascular effects of idarubicin in leukemia patients.
Topics: Antibiotics, Antineoplastic; Atrial Natriuretic Factor; Electrocardiography; Heart; Humans; Idarubicin; Injections, Intravenous; Myelodysplastic Syndromes; Natriuretic Peptide, Brain; Neurosecretory Systems | 1998 |
The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
Topics: Acute Disease; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Creatine Kinase, MB Form; Cytarabine; Echocardiography; Female; Heart Diseases; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Troponin T | 2005 |